New Mathematical Theorem Proves Children's Drug Doses Can Be Calculated With Certainty

LOS ANGELES - Rezul -- Primarch Michael A. Russell of the Universal Standard Axiom Corporation has introduced a new mathematical framework designed to revolutionize pediatric pharmacology.

His proposal suggests that children's drug dosages, which are traditionally provided as probabilistic ranges (such as 10 to 15 mg/kg), can instead be calculated as exact, verifiable values.

The Pediatric Constitutional Dosing Theorem, submitted to Academic Pediatrics, proves that for every child whose biological parameters are fully specified, one unique correct dose exists and is mathematically derivable.

"The therapeutic range is not a fact of biology," Russell states. "It is the mathematical record of every biological variable we chose not to measure. When we measure everything relevant, the range collapses to a number."

More on Rezul News

• Did Drake Just Find His Next Signee? Peoria Rapper Rhymi Gifts "ICEMANDRAKE" Domains, Drops Debut Album Same Day
• Andrew Tate Says Los Angeles Is "Where I Belong" as He Hints at USA Move
• AI Property Management: How Property Management AI Is Changing Housing and Real Estate
• Jennifer Susanne Sommers Highlights Luxury Development Growth in Boca Raton
• Jennifer Susanne Sommers Highlights Strength of Parkland Florida Luxury Real Estate

BACKGROUND

Dosing errors are among the most common preventable adverse events in pediatric medicine, occurring in an estimated 5 to 15 percent of hospital admissions involving children. Over 93 percent of drugs prescribed to children lack child-specific dosing data, forcing clinicians to rely on weight-based extrapolations from adult studies.

THE FRAMEWORK

The theorem introduces a seven-parameter biological vector — body composition, developmental stage, pharmacogenomic profile, microbiome state, circadian phase, comorbidity interactions, and real-time physiological state — and proves mathematically that dosing error decreases monotonically as each parameter is incorporated. When all parameters are measured, dosing error reaches zero.

Current standard of care typically incorporates only two of the seven parameters: weight and age.

The paper also formalizes the Pediatric Harm Amplification Principle — that dosing errors in children carry consequences far greater than equivalent errors in adults, due to developmental window irreversibility and lifetime impact.

More on Rezul News

• RAS AP Consulting Advances to Request for Proposal Stage in Heidelberg Materials' SAP Customer & Vendor Master Data Modernization Initiative
• Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
• VeneerVibe Releases 2026 Snap-On Veneers Market Report
• David Cavanagh Launches AI SEO Company For ChatGPT And AI Search Visibility
• Matthew Cossolotto Spotlights Make a Promise Day 2026 Events, Including Official Launch of Harness Your PromisePower and Issuing a "Peace Promise"

A structured seven-pass refinement protocol is provided for clinical implementation, along with seven specific empirical predictions and a full research agenda for prospective validation.

AVAILABILITY

The full manuscript (MARUSC-2026-PCDT-AP-001) has been submitted to Academic Pediatrics. All framework materials are released to the public domain under CC0 1.0 Universal for non-commercial academic use.

ABOUT ADVANCEER IVS LABS

Advanceer IVS Labs is the research division of Universal Standard Axiom Corporation, directed by Michael A. Russell, USPTO Category Creator in Operational Superintelligence and Machine Consciousness.

Contact: Michael@advanceerivs.com